The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
An update on the rotenone models of Parkinson's disease: Their ability to reproduce the features of clinical disease and model gene–environment interactions
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 4×
“emotional and cognitive disturbances associated with late stage PD (Braak et al., 2003; Halliday et al., 2011).”
BackgroundInfluentialMutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
The Nematode Caenorhabditis elegans
Wood, W. B. (1988) · Cold Spring Harbor Laboratory eBooks · Cited by 3,036
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
A Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 3×
“pathogenic pathway involved in PD (Clark et al., 2006; Park et al., 2006).”
BackgroundInfluentialMice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705
Rotenone, Paraquat, and Parkinson’s Disease
Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002839 · Cited by 1,475
Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,433
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno-Yagi, A., & Greenamyre, J. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,072
Parkinson's disease: a dual‐hit hypothesis
Hawkes, C. H., Del Tredici, K., & Braak, H. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00874.x · Cited by 1,021
Clinical progression in Parkinson disease and the neurobiology of axons
Cheng, H., Ulane, C. M., & Burke, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.21995 · Cited by 1,012 · cited 1×
“Degeneration induced in the rodent rotenone model reproduces the degeneration in clinical PD (Cheng et al., 2010), with damage occurring in the dopaminergic nerve terminals of the striatum and cell bodies in the SN (Betarbet et al.”
BackgroundZhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974
Eng, L. F., & Ghirnikar, R. S. (1994) · Brain Pathology · doi:10.1111/j.1750-3639.1994.tb00838.x · Cited by 864
A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease
Zimprich, A., Benet-Pagès, A., Struhal, W., Graf, E., Eck, S. H., Offman, M. N., Haubenberger, D., Spielberger, S., Schulte, E. C., Lichtner, P., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.008 · Cited by 816
Parkinson’s disease: genetics and pathogenesis
Shulman, J. M., De Jager, P. L., & Feany, M. B. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130242 · Cited by 801
A highly reproducible rotenone model of Parkinson's disease
Cannon, J. R., Tapias, V., Na, H. M., Honick, A. S., Drolet, R. E., & Greenamyre, J. T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.016 · Cited by 795
Imai, Y., Soda, M., & Takahashi, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000447200 · Cited by 766
Duty, S., & Jenner, P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01426.x · Cited by 753
Sherer, T. B., Kim, J.-H., Betarbet, R., & Greenamyre, J. T. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 708
Kim, R. H., Smith, P. D., Aleyasin, H., Hayley, S., Mount, M. P., Pownall, S., Wakeham, A., You-Ten, A. J., Kalia, S. K., Horne, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501282102 · Cited by 701
Diagnosis and treatment of Parkinson disease: molecules to medicine
Savitt, J. M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29178 · Cited by 650
Animal models of Parkinson's disease
Betarbet, R., Sherer, T. B., & Greenamyre, J. T. (2002) · BioEssays · doi:10.1002/bies.10067 · Cited by 592
Nuytemans, K., Theuns, J., Cruts, M., & Van Broeckhoven, C. (2010) · Human Mutation · doi:10.1002/humu.21277 · Cited by 563
Invited Article: Nervous system pathology in sporadic Parkinson disease
Braak, H., & Del Tredici, K. (2008) · Neurology · doi:10.1212/01.wnl.0000312279.49272.9f · Cited by 538
Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses
Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E., & Ikuta, F. (1988) · Acta Neuropathologica · doi:10.1007/bf00687767 · Cited by 528
de Rijk, M. C., Launer, L. J., Berger, K., Breteler, M. M. B., Dartigues, J. F., Baldereschi, M., Fratiglioni, L., Lobo, A., Martinez-Lage, J., Trenkwalder, C., et al. (2000) · PubMed · Cited by 528
Pan-Montojo, F., Anichtchik, O., Dening, Y., Knels, L., Pursche, S., Jung, R., Jackson, S., Gille, G., Spillantini, M. G., Reichmann, H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008762 · Cited by 524
Prevalence of Parkinson's disease in Europe : A collaborative study of population-based cohorts
de Rijk, M. C., Launer, L. J., Berger, K., Breteler, M. M. B., Dartigues, J. F., Baldereschi, M., Fratiglioni, L., Lobo, A., Martínez‐Lage, J. M., Trenkwalder, C., et al. (2000) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 514
Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin
Exner, N., Treske, B., Paquet, D., Holmström, K., Schiesling, C., Gispert, S., Carballo-Carbajal, I., Berg, D., Hoepken, H.-H., Gasser, T., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0719-07.2007 · Cited by 513
PINK1 mutations are associated with sporadic early‐onset parkinsonism
Valente, E. M., Salvi, S., Ialongo, T., Marongiu, R., Elia, A. E., Caputo, V., Romito, L., Albanese, A., Dallapiccola, B., & Bentivoglio, A. R. (2004) · Annals of Neurology · doi:10.1002/ana.20256 · Cited by 505
Tong, Y., Yamaguchi, H., Giaime, E., Boyle, S., Kopan, R., Kelleher, R. J., & Shen, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004676107 · Cited by 501
Oxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases
Choi, J., Sullards, M. C., Olzmann, J. A., Rees, H. D., Weintraub, S. T., Bostwick, D. E., Gearing, M., Levey, A. I., Chin, L.-S., & Li, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509079200 · Cited by 483
Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats
Alam, M., & Schmidt, W. J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00180-8 · Cited by 473
DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy
Thomas, K. J., McCoy, M. K., Blackinton, J., Beilina, A., van der Brug, M., Sandebring, A., Miller, D., Maric, D., Cedazo-Minguez, A., & Cookson, M. R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq430 · Cited by 454
Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism
Silvestri, L., Caputo, V., Bellacchio, E., Atorino, L., Dallapiccola, B., Valente, E. M., & Casari, G. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi377 · Cited by 450
Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease
Harding, A. J., Stimson, E., Henderson, J. M., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf251 · Cited by 443
Olfaction in Parkinson's disease and related disorders
Doty, R. L. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.026 · Cited by 431
Chronic Exposure to Rotenone Models Sporadic Parkinson's Disease in Drosophila melanogaster
Coulom, H., & Birman, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2993-04.2004 · Cited by 421
Gispert, S., Ricciardi, F., Kurz, A., Azizov, M., Hoepken, H.-H., Becker, D., Voos, W., Leuner, K., Müller, W. E., Kudin, A. P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005777 · Cited by 381
Gastrointestinal symptoms in Parkinson's disease
Edwards, L. L., Pfeiffer, R. F., Quigley, E. M. M., Hofman, R., & Balluff, M. (1991) · Movement Disorders · doi:10.1002/mds.870060211 · Cited by 375
Singaram, C., Gaumnitz, E. A., Torbey, C., Ashraf, W., Quigley, E. M. M., Sengupta, A., & Pfeiffer, R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92707-7 · Cited by 368
Meulener, M., Whitworth, A. J., Armstrong-Gold, C. E., Rizzu, P., Heutink, P., Wes, P. D., Pallanck, L. J., & Bonini, N. M. (2005) · Current Biology · doi:10.1016/j.cub.2005.07.064 · Cited by 353
Betarbet, R., Canet-Aviles, R. M., Sherer, T. B., Mastroberardino, P. G., McLendon, C., Kim, J.-H., Lund, S., Na, H.-M., Taylor, G., Bence, N. F., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.003 · Cited by 342
Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes
Bonifati, V., Rohé, C. F., Breedveld, G. J., Fabrizio, E., De Mari, M., Tassorelli, C., Tavella, A., Marconi, R., Nicholl, D. J., Chien, H. F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000167546.39375.82 · Cited by 338
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
Höglinger, G. U., Féger, J., Prigent, A., Michel, P. P., Parain, K., Champy, P., Ruberg, M., Oertel, W. H., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01533.x · Cited by 331
Pandi-Perumal, S. R., BaHammam, A. S., Brown, G. M., Spence, D. W., Bharti, V. K., Kaur, C., Hardeland, R., & Cardinali, D. P. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9337-4 · Cited by 320
Cersosimo, M. G., Raina, G. B., Pecci, C., Pellene, A., Calandra, C. R., Gutiérrez, C., Micheli, F. E., & Benarroch, E. E. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6801-2 · Cited by 314
Huisman, E., Uylings, H. B. M., & Hoogland, P. V. (2004) · Movement Disorders · doi:10.1002/mds.10713 · Cited by 313
Cicchetti, F., Drouin-Ouellet, J., & Gross, R. E. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.06.005 · Cited by 311
Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease
Bretaud, S., Lee, S., & Guo, S. (2004) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2004.06.014 · Cited by 305
Heikkila, R. E., Nicklas, W. J., Vyas, I., & Duvoisin, R. C. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90580-4 · Cited by 300
Gastrointestinal dysfunction in Parkinson's disease
Pfeiffer, R. F. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.08.003 · Cited by 298
LRRK2 Controls Synaptic Vesicle Storage and Mobilization within the Recycling Pool
Piccoli, G., Condliffe, S. B., Bauer, M., Giesert, F., Boldt, K., De Astis, S., Meixner, A., Sarioglu, H., Vogt-Weisenhorn, D. M., Wurst, W., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3730-10.2011 · Cited by 267
Toxin Models of Mitochondrial Dysfunction in Parkinson's Disease
Martinez, T. N., & Greenamyre, J. T. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4033 · Cited by 266
Neuropathology of non-motor features of Parkinson disease
Dickson, D. W., Fujishiro, H., Orr, C., DelleDonne, A., Josephs, K. A., Frigerio, R., Burnett, M., Parisi, J. E., Klos, K. J., & Ahlskog, J. E. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70769-2 · Cited by 266
Inden, M., Kitamura, Y., Takeuchi, H., Yanagida, T., Takata, K., Kobayashi, Y., Taniguchi, T., Yoshimoto, K., Kaneko, M., Okuma, Y., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04440.x · Cited by 260
Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology
Drolet, R. E., Cannon, J. R., Montero, L., & Greenamyre, J. T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.017 · Cited by 257
Ved, R., Saha, S., Westlund, B., Perier, C., Burnam, L., Sluder, A., Hoener, M., Rodrigues, C. M. P., Alfonso, A., Steer, C., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505910200 · Cited by 255
Santiago, R. M., Barbieiro, J., Lima, M. M. S., Dombrowski, P. A., Andreatini, R., & Vital, M. A. B. F. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.004 · Cited by 252
α-Synuclein gene duplication is present in sporadic Parkinson disease
Ahn, T. B., Kim, S. Y., Kim, J. Y., Park, S. S., Lee, D. S., Min, H. J., Kim, Y. K., Kim, S. E., Kim, J. M., Kim, H. J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000271080.53272.c7 · Cited by 249
Novel PINK1 mutations in early‐onset parkinsonism
Hatano, Y., Li, Y., Sato, K., Asakawa, S., Yamamura, Y., Tomiyama, H., Yoshino, H., Asahina, M., Kobayashi, S., Hassin‐Baer, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20251 · Cited by 245
LRRK2 Modulates Vulnerability to Mitochondrial Dysfunction in Caenorhabditis elegans
Saha, S., Guillily, M. D., Ferree, A., Lanceta, J., Chan, D., Ghosh, J., Hsu, C. H., Segal, L., Raghavan, K., Matsumoto, K., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2281-09.2009 · Cited by 243
FLEMING, S. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.023 · Cited by 230
Pathological lesions in colonic biopsies during Parkinson’s disease
Lebouvier, T., Chaumette, T., Damier, P., Coron, E., Touchefeu, Y., Vrignaud, S., Naveilhan, P., Galmiche, J.-P., Bruley des Varannes, S., Derkinderen, P., et al. (2008) · Gut · doi:10.1136/gut.2008.162503 · Cited by 229
Novel PINK1 mutations in early-onset parkinsonism
波田野, 靖. (2005) · Medical Entomology and Zoology · Cited by 227
Burn, D. J. (2002) · Movement Disorders · doi:10.1002/mds.10114 · Cited by 223
Karuppagounder, S. S., Madathil, S. K., Pandey, M., Haobam, R., Rajamma, U., & Mohanakumar, K. P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.032 · Cited by 223
Drosophila in the Study of Neurodegenerative Disease
Marsh, J. L., & Thompson, L. M. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.025 · Cited by 212
Parkin Protects against LRRK2 G2019S Mutant-Induced Dopaminergic Neurodegeneration in Drosophila
Ng, C.-H., Mok, S. Z. S., Koh, C., Ouyang, X., Fivaz, M. L., Tan, E.-K., Dawson, V. L., Dawson, T. M., Yu, F., & Lim, K.-L. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2375-09.2009 · Cited by 211
(2000) · Neurology · doi:10.1212/wnl.54.5.21a · Cited by 209
Paralysis agitans. I. Pathologische Anatomie
Lewy, F. (1912) · Medical Entomology and Zoology · Cited by 208
Mizuta, I., Satake, W., Nakabayashi, Y., Ito, C., Suzuki, S., Momose, Y., Nagai, Y., Oka, A., Inoko, H., Fukae, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl030 · Cited by 207
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy
Höglinger, G. U., Lannuzel, A., Khondiker, M. E., Michel, P. P., Duyckaerts, C., Féger, J., Champy, P., Prigent, A., Medja, F., Lombes, A., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03493.x · Cited by 203
Xiong, N., Long, X., Xiong, J., Jia, M., Chen, C., Huang, J., Ghoorah, D., Kong, X., Lin, Z., & Wang, T. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.680431 · Cited by 201
St. Laurent, R., O’Brien, L. M., & Ahmad, S. T. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.037 · Cited by 199
α‐Synuclein produces a long‐lasting increase in neurotransmitter release
Liu, S., Ninan, I., Antonova, I., Battaglia, F., Trinchese, F., Narasanna, A., Kolodilov, N., Dauer, W., Hawkins, R. D., & Arancio, O. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600451 · Cited by 198
Nigral and extranigral pathology in Parkinson's disease.
Braak, H., Braak, E., Yilmazer‐Hanke, D., Schultz, C., de Vos, R. A. I., & Jansen, E. N. H. (1995) · PubMed · Cited by 198
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease
Ross, O. A., Wu, Y., Lee, M., Funayama, M., Chen, M., Soto, A. I., Mata, I. F., Lee‐Chen, G., Chen, C. M., Tang, M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21405 · Cited by 196
GTPase Activity Plays a Key Role in the Pathobiology of LRRK2
Xiong, Y., Coombes, C. E., Kilaru, A., Li, X., Gitler, A. D., Bowers, W. J., Dawson, V. L., Dawson, T. M., & Moore, D. J. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000902 · Cited by 196
Milestones in Parkinson's disease—Clinical and pathologic features
Halliday, G., Lees, A., & Stern, M. (2011) · Movement Disorders · doi:10.1002/mds.23669 · Cited by 196
Neural control of the gastrointestinal tract: Implications for Parkinson disease
Cersosimo, M. G., & Benarroch, E. E. (2008) · Movement Disorders · doi:10.1002/mds.22051 · Cited by 188
Rotenone induces non‐specific central nervous system and systemic toxicity
Lapointe, N., St‐Hilaire, M., Martinoli, M., Blanchet, J., Gould, P., Rouillard, C., & Cicchetti, F. (2004) · The FASEB Journal · doi:10.1096/fj.03-0677fje · Cited by 187
Hedrich, K., Djarmati, A., Schäfer, N., Hering, R., Wellenbrock, C., Weiss, P. H., Hilker, R., Vieregge, P., Ozelius, L. J., Heutink, P., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000113022.51739.88 · Cited by 185
Venderova, K., Kabbach, G., Abdel-Messih, E., Zhang, Y., Parks, R. J., Imai, Y., Gehrke, S., Ngsee, J., LaVoie, M. J., Slack, R. S., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp394 · Cited by 184
Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio)
Flinn, L., Mortiboys, H., Volkmann, K., Koster, R. W., Ingham, P. W., & Bandmann, O. (2009) · Brain · doi:10.1093/brain/awp108 · Cited by 184
Loss of PINK1 Function Affects Development and Results in Neurodegeneration in Zebrafish
Anichtchik, O., Diekmann, H., Fleming, A., Roach, A., Goldsmith, P., & Rubinsztein, D. C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0979-08.2008 · Cited by 178
Mundiñano, I.-C., Caballero, M.-C., Ordóñez, C., Hernandez, M., DiCaudo, C., Marcilla, I., Erro, M.-E., Tuñon, M.-T., & Luquin, M.-R. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0830-2 · Cited by 173
Hosamani, R., & ., M. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.08.012 · Cited by 173
The neuropathological basis for depression in Parkinson's disease
Frisina, P. G., Haroutunian, V. H., & Libow, L. S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.04.038 · Cited by 173
Kaur, H., Chauhan, S., & Sandhir, R. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0469-3 · Cited by 171
Inden, M., Kitamura, Y., Abe, M., Tamaki, A., Takata, K., & Taniguchi, T. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.92 · Cited by 168
Lessons from the rotenone model of Parkinson's disease
Greenamyre, J. T., Cannon, J. R., Drolet, R., & Mastroberardino, P.-G. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.12.006 · Cited by 166
Greene, J. G., Noorian, A. R., & Srinivasan, S. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.023 · Cited by 165
Protective effect of melatonin in a chronic experimental model of Parkinson’s disease
Antolı́n, I., Mayo, J. C., Sainz, R. M., del Brı́o, M. D. L. A., Herrera, F., Martı́n, V., & Rodrı́guez, C. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02551-9 · Cited by 163
The importance of non-motor disturbances to quality of life in Parkinson's disease
Martinez-Martin, P. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.05.006 · Cited by 160
Behavior and Its Neural Control in Gastropod Molluscs
Chase, R. (2002) · Cited by 154
Role of Mendelian genes in “sporadic” Parkinson's disease
Lesage, S., & Brice, A. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70022-0 · Cited by 153
Expanding the clinical phenotype of SNCA duplication carriers
Nishioka, K., Ross, O. A., Ishii, K., Kachergus, J. M., Ishiwata, K., Kitagawa, M., Kono, S., Obi, T., Mizoguchi, K., Inoue, Y., et al. (2009) · Movement Disorders · doi:10.1002/mds.22682 · Cited by 147
Valeriana officinalis attenuates the rotenone-induced toxicity in Drosophila melanogaster
Sudati, J. H., Vieira, F. A., Pavin, S. S., Dias, G. R. M., Seeger, R. L., Golombieski, R. M., Athayde, M. L., Soares, F. A. A., da Rocha, J. B. T., & Barbosa, N. V. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.04.006 · Cited by 146
Zebrafish as a new animal model for movement disorders
Flinn, L., Bretaud, S., Lo, C., Ingham, P. W., & Bandmann, O. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05463.x · Cited by 145
Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease
Yacoubian, T. A., Slone, S. R., Harrington, A. J., Hamamichi, S., Schieltz, J. M., Caldwell, K. A., Caldwell, G. A., & Standaert, D. G. (2010) · Cell Death and Disease · doi:10.1038/cddis.2009.4 · Cited by 143
Wang, C., Lu, R., Ouyang, X., Ho, M. W. L., Chia, W. N., Yu, F., & Lim, K. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0218-07.2007 · Cited by 139
Saravanan, K. S., Madathil, S. K., & Mohanakumar, K. P. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.051 · Cited by 135
Role of nitric oxide in rotenone‐induced nigro‐striatal injury
He, Y., Imam, S. Z., Dong, Z., Jankovic, J. J., Ali, S. F., Appel, S. H., & Le, W. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01938.x · Cited by 133
Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease
Xiong, N., Huang, J., Zhang, Z., Zhang, Z., Xiong, J., Liu, X., Jia, M., Wang, F., Chen, C., Cao, X., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007878 · Cited by 133
Refractory Nonmotor Symptoms in Male Patients With Parkinson Disease Due to Testosterone Deficiency
Okun, M. S. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.807 · Cited by 132
Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons
Wang, D., Tang, B., Zhao, G., Pan, Q., Xia, K., Bodmer, R., & Zhang, Z. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-3 · Cited by 128
Sleep disturbances in Parkinson's disease: The contribution of dopamine in REM sleep regulation
Lima, M. M. S. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.10.006 · Cited by 128
Neurobiology of Depression and Anxiety in Parkinson's Disease
Kano, O., Ikeda, K., Cridebring, D., Takazawa, T., Yoshii, Y., & Iwasaki, Y. (2011) · Parkinson s Disease · doi:10.4061/2011/143547 · Cited by 126
Homozygous PINK1 C‐terminus mutation causing early‐onset parkinsonism
Rohé, C. F., Montagna, P., Breedveld, G. J., Cortelli, P., Oostra, B. A., & Bonifati, V. (2004) · Annals of Neurology · doi:10.1002/ana.20247 · Cited by 126
Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson’s disease
Bardien, S., Lesage, S., Brice, A., & Carr, J. A. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.11.008 · Cited by 124
Genetics of Parkinson's disease
Gasser, T. (2001) · Journal of Neurology · doi:10.1007/s004150170066 · Cited by 124
Linhart, R., Wong, S. A., Cao, J., Tran, M. L., Huynh, A., Ardrey, C., Park, J. M., Hsu, C., Taha, S., Peterson, R., et al. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-23 · Cited by 122
Transgenic zebrafish models of neurodegenerative diseases
Sager, J. J., Bai, Q., & Burton, E. A. (2010) · Brain Structure and Function · doi:10.1007/s00429-009-0237-1 · Cited by 122
Synuclein deposition and non-motor symptoms in Parkinson disease
Jellinger, K. A. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.04.012 · Cited by 119
Naturally Occurring Insecticides
Soloway, S. B. (1976) · Environmental Health Perspectives · doi:10.1289/ehp.7614109 · Cited by 117
Ray, A., Martinez, B., Berkowitz, L. A., Caldwell, G. A., & Caldwell, K. A. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.513 · Cited by 117
Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease
Marella, M., Seo, B. B., Nakamaru-Ogiso, E., Greenamyre, J. T., Matsuno-Yagi, A., & Yagi, T. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001433 · Cited by 116 · cited 2×
“burst followed by sustained release and is reported to produce both behavioral and pathological PD changes (Ferris et al., 2013; Huang et al., 2006; Marella et al., 2008).”
BackgroundFeany, M. Β., & Pallanck, L. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00201-0 · Cited by 115
Genetics of Parkinson's disease.
Gasser, T. (2004) · Europe PMC (PubMed Central) · Cited by 111
Huisman, E., Uylings, H. B. M., & Hoogland, P. V. J. M. (2008) · Movement Disorders · doi:10.1002/mds.22009 · Cited by 106
PINK1 mutations in sporadic early‐onset Parkinson's disease
Tan, E., Yew, K., Chua, E., Puvan, K., Shen, H., Lee, E., Puong, K., Zhao, Y., Ratnagopal, P., Wong, M. C., et al. (2006) · Movement Disorders · doi:10.1002/mds.20810 · Cited by 105
Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease
Tapias, V., Cannon, J. R., & Greenamyre, J. T. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.077 · Cited by 103
MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut
Natale, G., Kastsiushenka, O., Fulceri, F., Ruggieri, S. A., Paparelli, A., & Fornai, F. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.076 · Cited by 101
Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model
Tapias, V., Cannon, J. R., & Greenamyre, J. T. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22201 · Cited by 97
Effects of oral administration of rotenone on gastrointestinal functions in mice
Tasselli, M., Chaumette, T., Paillusson, S., Monnet, Y., Lafoux, A., Huchet, C., Aubert, P., Hunot, S., Derkinderen, P., & Neunlist, M. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12070 · Cited by 96
Navarro, J. A., Heßner, S., Yenisetti, S. C., Bayersdorfer, F., Zhang, L., Voigt, A., Schneuwly, S., & Botella, J. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12818 · Cited by 96
Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease
Sharma, R., McMillan, C. R., Tenn, C. C., & Niles, L. P. (2005) · Brain Research · doi:10.1016/j.brainres.2005.10.084 · Cited by 96
Bassani, T. B., Gradowski, R. W., Zaminelli, T., Barbiero, J. K., Santiago, R. M., Boschen, S. L., Cunha, C. D., Lima, M. M. S., Andreatini, R., & Vital, M. A. B. F. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.068 · Cited by 95
Angeline, M. S., Chaterjee, P., Anand, K., Ambasta, R. K., & Kumar, P. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.06.021 · Cited by 95
Hosamani, R., Ramesh, S. R., & ., M. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0198-z · Cited by 94
Prediger, R. D., Aguiar, A. S., MATHEUS, F. C., Walz, R., Antoury, L., Raisman‐Vozari, R., & Doty, R. L. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9281-8 · Cited by 93
Lin, C., Huang, J.-Y., Ching, C., & Chuang, J. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00510.x · Cited by 92
Rojo, A. I., Cavada, C., de Sagarra, M. R., & Cuadrado, A. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.022 · Cited by 83
Lawal, H. O., Chang, H.-Y., Terrell, A. N., Brooks, E. S., Pulido, D., Simon, A. F., & Krantz, D. E. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.008 · Cited by 82
Alam, M., Mayerhofer, A., & Schmidt, W. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.08.014 · Cited by 82
Cannon, J. R., Geghman, K. D., Tapias, V., Sew, T., Dail, M. K., Li, C., & Greenamyre, J. T. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.11.007 · Cited by 81
Jelliffe (1911) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-191105000-00015 · Cited by 80
Zebrafish DJ-1 is evolutionarily conserved and expressed in dopaminergic neurons
Bai, Q., Mullett, S. J., Garver, J. A., Hinkle, D. A., & Burton, E. A. (2006) · Brain Research · doi:10.1016/j.brainres.2006.07.057 · Cited by 79
Sindhu, K. M., Saravanan, K. S., & Mohanakumar, K. P. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.051 · Cited by 78
Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity
Perez, F. A., Curtis, W., & Palmiter, R. D. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-71 · Cited by 75
Ravenstijn, P. G. M., Merlini, M., Hameetman, M., Murray, T. K., Ward, M., Lewis, H., Ball, G., Mottart, C., de Goyet, C. D. V., Lemarchand, T., et al. (2007) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2007.10.003 · Cited by 75
Sharma, N., & Nehru, B. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.3.214 · Cited by 72
Plasma testosterone levels in Alzheimer and Parkinson diseases
Okun, M. S., DeLong, M. R., Hanfelt, J., Gearing, M., & Levey, A. I. (2004) · Neurology · doi:10.1212/01.wnl.0000106840.72938.84 · Cited by 72
Thakur, P. S., & Nehru, B. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.11.006 · Cited by 67
Striatal neuroprotection with methylene blue
Rojas, J. C., Simola, N., Kermath, B. A., Kane, J. R., Schallert, T. J., & Gonzalez-Lima, F. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.07.012 · Cited by 62
Antidepressant and Antioxidative Effect of Ibuprofen in the Rotenone Model of Parkinson’s Disease
Zaminelli, T., Gradowski, R. W., Bassani, T. B., Barbiero, J. K., Santiago, R. M., Ferreira, D. M., Baggio, C. H., & Vital, M. A. B. F. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9467-y · Cited by 61
Krishna, G., & ., M. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1323-1 · Cited by 60
LRRK2 R1628P increases risk of Parkinson’s disease: replication evidence
Tan, E., Tan, L. C. S., Lim, H., Li, R., Tang, M., Yih, Y., Pavanni, R., Prakash, K. M., Fook-Chong, S. M. C., & Zhao, Y. (2008) · Human Genetics · doi:10.1007/s00439-008-0544-2 · Cited by 59
Rodrigues, L. S., Targa, A., Noseda, A. C. D., Aurich, M. F., Cunha, C. D., & Lima, M. M. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00383 · Cited by 58
Interleukin-1β Mediates Sleep Alteration in Rats With Rotenone-Induced Parkinsonism
Yi, P.-L., Tsai, C., Lu, M., Liu, H.-J., Chen, Y.-C., & Chang, F. (2007) · SLEEP · doi:10.1093/sleep/30.4.413 · Cited by 58
The Rotenone model of Parkinsonism — the five years inspection
Höglinger, G. U., Oertel, W. H., & Hirsch, É. C. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_41 · Cited by 57
Mocko, J. B., Kern, A., Moosmann, B., Behl, C., & Hajieva, P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.019 · Cited by 55
Chandran, G., & ., M. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.04.002 · Cited by 54
An effective novel delivery strategy of rasagiline for Parkinson's disease
Fernández, M., Negro, S., Slowing, K., Fernández-Carballido, A. M., & Barcia, E. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.029 · Cited by 51
Morais, L. H., Lima, M. M. S., Martynhak, B. J., Santiago, R. M., Takahashi, T. T., Ariza, D., Barbiero, J. K., Andreatini, R., & Vital, M. A. B. F. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70905-2 · Cited by 50
Salam, S., Ansari, A., Amon, S., Rezai, P., Selvaganapathy, P. R., Mishra, R. K., & Gupta, B. P. (2013) · Worm · doi:10.4161/worm.24558 · Cited by 48
George, S., Mok, S. S., Nurjono, M., Ayton, S., Finkelstein, D. I., Masters, C. L., Li, Q., & Culvenor, J. G. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9378-1 · Cited by 47
Mulcahy, P. J., Walsh, S. R., Paucard, A., Rea, K., & Dowd, E. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.01.038 · Cited by 46
Investigating Convergent Actions of Genes Linked to Familial Parkinson’s Disease
Wolozin, B. L., Saha, S., Guillily, M. D., Ferree, A. W., & Riley, M. M. (2008) · Neurodegenerative Diseases · doi:10.1159/000113697 · Cited by 46
dos Santos, A. C., Castro, M. A. V., Jose, E. A. K., Delattre, A. M., Dombrowski, P. A., Cunha, C. D., Ferraz, A. C., & Lima, M. M. S. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23258 · Cited by 45
Islam, R., Yang, L., Sah, M., Kannan, K., Anamani, D. E., Vijayan, C., Kwok, J., Cantino, M. E., Beal, M. F., & Fridell, Y.-W. C. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.055 · Cited by 45
Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson’s disease
Carriere, C. H., Kang, N. H., & Niles, L. P. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.02.028 · Cited by 45
Sleep disturbances in the rotenone animal model of Parkinson disease
García‐García, F., Ponce, S., Brown, R. A., Cussen, V. A., & Krueger, J. M. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.036 · Cited by 45
Fernández, M., Barcia, E., Fernández-Carballido, A. M., García‐García, L., Slowing, K., & Negro, S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.024 · Cited by 42
Wu, L., Tian, Y., Shi, J., Xie, W., Shi, J., Lu, J., & Zhang, Y. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.008 · Cited by 42
MORGAN, W. W., & Nelson, J. F. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03106-7 · Cited by 41
LRRK2 in Parkinson’s disease: function in cells and neurodegeneration
Webber, P. J., & West, A. B. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07342.x · Cited by 40
Hwang, R., Wiemerslage, L., LaBreck, C. J., Khan, M. H., Kannan, K., Wang, X., Zhu, X., Lee, D., & Fridell, Y.-W. C. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.032 · Cited by 40
Murakami, S., Miyazaki, I., Sogawa, N., Miyoshi, K., & Asanuma, M. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9480-1 · Cited by 40
LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han‐Chinese from mainland China
Zhang, Z., Burgunder, J., An, X., Wu, Y. P., Chen, W., Zhang, J., Wang, Y., Xu, Y., Gou, Y., Yuan, G., et al. (2009) · Movement Disorders · doi:10.1002/mds.22371 · Cited by 39
Chandran, G., & ., M. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9959-y · Cited by 37
A delivery strategy for rotenone microspheres in an animal model of Parkinson's disease
Huang, J., Liu, H., Gu, W., Yan, Z., Xu, Z., Yang, Y., Zhu, X., & Li, Y. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.07.005 · Cited by 36
A phenotypic model recapitulating the neuropathology of P arkinson's disease
Ferris, C. F., Marella, M., Smerkers, B., Barchet, T. M., Gershman, B., Matsuno‐Yagi, A., & Yagi, T. (2013) · Brain and Behavior · doi:10.1002/brb3.138 · Cited by 34
Circadian Dysfunction in a Rotenone-Induced Parkinsonian Rodent Model
Lax, P., Esquiva, G., Esteve-Rudd, J., Baño‐Otálora, B., Madrid, J. A., & Cuenca, N. (2012) · Chronobiology International · doi:10.3109/07420528.2011.649870 · Cited by 33
Mulcahy, P. J., O’Doherty, A., Paucard, A., O’Brien, T., Kirik, D., & Dowd, E. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.051 · Cited by 33
Zhou, S., Wang, Z., & Klaunig, J. E. (2013) · Europe PMC (PubMed Central) · Cited by 32
Sodium salicylate protects against rotenone-induced Parkinsonism in rats
Madathil, S. K., Karuppagounder, S. S., & Mohanakumar, K. P. (2013) · Synapse · doi:10.1002/syn.21658 · Cited by 30
Alam, M., & SCHMIDT, W. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.08.010 · Cited by 29
Subramanian, P., Prasanna, V., Jayapalan, J. J., Abdul‐Rahman, P. S., & Hashim, O. H. (2014) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2014.04.005 · Cited by 25
Colchicine Protects Dopaminergic Neurons in a Rat Model of Parkinson's Disease
Salama, M., Ellaithy, A., Helmy, B., El‐Gamal, M., El‐Tantawy, D., Mohamed, M., Sheashaa, H., Sobh, M. A. K., & Arias-Carrión, Ó. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311201070836 · Cited by 25
Jia, F., Song, N., Zhao, C., Xie, J., & Jiang, H. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091641 · Cited by 22
Suetomi, K., Mereiter, S., Mori, C., Takanami, T., & Higashitani, A. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.02.004 · Cited by 9
Rotenone Use in Fish Management and Parkinson's Disease: Another Look
Finlayson, B. J., Schnick, R. A., Skaar, D., Anderson, J. D., DeMong, L., Duffield, D., Horton, W., Steinkjer, J., & VanMaaren, C. (2012) · Fisheries · doi:10.1080/03632415.2012.723963 · Cited by 7
Cited by
A perspective on multi‐target drug discovery and design for complex diseases
Ramsay, R. R., Popovic‐Nikolic, M. R., Nikolic, K., Uliassi, E., & Bolognesi, M. L. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0181-2 · Cited by 718
Zhao, Z., Ning, J., Bao, X.-Q., Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Microbiome · doi:10.1186/s40168-021-01107-9 · Cited by 616
Richardson, J. R., Fitsanakis, V., Westerink, R. H. S., & Kanthasamy, A. G. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02033-9 · Cited by 539
Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells
Monzel, A. S., Smits, L. M., Hemmer, K., Hachi, S., Moreno, E. L., van Wuellen, T., Jarazo, J., Walter, J., Brüggemann, I., Boussaad, I., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.03.010 · Cited by 435
Elfawy, H. A., & Das, B. (2019) · Life Sciences · doi:10.1016/j.lfs.2018.12.029 · Cited by 343
Metadata
- Authors
- Johnson, M. E., & Bobrovskaya, L.
- Venue
- NeuroToxicology
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 46
- Pages
- 101-116
- ISSN
- 0161-813X (ISSN-L)
- OpenAlex
- W2036863248
- Cited by
- 332
- References
- 192
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.